RANDs Penny Stocks
RANDs Penny Stocks
West Coast Trading Group
Friday, June 10, 2011
IFRS "bioinformation"
SILVERDALE, Wash., June 10, 2011 -- Infrared Systems International (IFRS) subsidiary, AquaLiv, Inc., has released an explanatory statement about its BioT(TM) Bioinformation Technology. AquaLiv received an overwhelming number of technical inquiries this week as a result of its recent announcement that its pilot HIV/AIDS study showed tremendous results and did not rely on any active molecule. According to the announcement, the company's treatment "resembles common mineral water in analysis." "The basis of our technology has nothing to do with water," answered AquaLiv CEO Craig Hoffman. "We merely use water as a delivery vehicle for our treatment. In actuality, it is the few mineral ions in water that resemble the ions in magnetic video or audio tape that are of our concern. Just as the VHS tapes of yesterday contained rich audio and visual information, we program our wave-based information composites into these mineral ions - it is the same concept. Our NatuRx(TM) treatments contain a water we ourselves manufacture with known concentrations of these ions. It's the only way to guarantee performance." According to the company's website, the technology is based on its discovery that all organisms utilize a barcode-like language to interact with their environment more efficiently. By communicating with organisms through this language, the company can create desired responses without using chemicals. The company refers to this biological barcode as "bioinformation." "As it relates to medicine, we believe our treatments can be converted to tablets. This would represent a large cost savings to us as we scale, but for the purposes of our medical research, it makes no sense to explore this now - our scientific staff is working at capacity," added Mr. Hoffman. "In clinical situations, we envision the future of our technology utilizes computer automated. An MRI-like machine will scan the patient for localized bioinformation anomalies, compute a waveform correction treatment, and broadcast the treatment directly into the patient." AquaLiv's patented BioT(TM) Bioinformation Technology is the basis for numerous products and industrial solutions including the AgSmart(TM) line of agriculture enhancement products and the upcoming NatuRx(TM) treatments for a variety of diseases. The technology utilizes novel wave-based information composites in lieu of molecules. "The technology is difficult for many people to wrap their head around - I know it was for me," stated Bill Wright, CEO of Infrared Systems International. "It takes an effort to dig in and understand what is occurring - and the results speak volumes."
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment